Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
about
Pancreatic β-cell proliferation in obesity.GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.Glucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice.A dose-response strategy reveals differences between normal-weight and obese men in their metabolic and inflammatory responses to a high-fat meal.β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity.Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes.Physiology of incretins in health and disease.Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes.Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion.Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4.Metabolic and Hormonal Response to a Feed-challenge Test in Lean and Overweight Dogs.Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro.The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.Nutrient-specific feeding and endocrine effects of jejunal infusions in obese animals.Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index.GLP-1 and energy balance: an integrated model of short-term and long-term controlGlucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders.Incretin hormones and the satiation signal.Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Intestinal GLP-1 and satiation: from man to rodents and back.Performance of individually-measured vs population-based C-peptide kinetics to assess β-cell function in presence and absence of acute insulin resistance.Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction.DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposityDiurnal rhythms of plasma GLP-1 levels in normal and overweight/obese subjects: lack of effect of weight loss.Alterations in circadian and meal-induced gut peptide levels in lean and obese rats.Lifestyle change reduces cardiometabolic risk factors and glucagon-like peptide-1 levels in obese first-degree relatives of people with diabetes.Effect of heart failure on dipeptidyl peptidase IV activity in plasma of dogs.Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.The metabolic syndrome influences the response to incretin-based therapies.Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects.Dissociated incretin hormone response to protein versus fat ingestion in obese subjects
P2860
Q33578671-D18F5484-DA28-4374-ACE5-C70D0902FADAQ33745485-AE77DBC1-EB0F-4F75-8475-C96F4BC26B59Q33800196-93324D07-BD62-42B9-AB7B-49A36F9A9B1FQ34171916-A4276F23-2777-447F-9EAB-4555123010DCQ35680897-528A457A-283E-4203-AAEE-5E7E162F0AC8Q35744498-49284215-A6F2-4CDB-9A16-2661B2C4CBBFQ35760279-C0FD8223-8EDA-45C2-BA08-A4E717BCA89DQ35827899-C06C0839-42A7-4AEF-8E9B-327427F3D29EQ36850966-EFE1CB17-B56A-4BAA-B6D9-50689C92F2D9Q36924521-B18A2CCB-B57E-45EE-86B0-4A107F62E29CQ37015014-767A4B0B-42F2-4CC2-95B9-C5E7922F39DEQ37020330-963DBA41-0644-4335-87F3-085F6212008AQ37106470-A60B00E2-1E5B-402D-A473-FE246E4BD8C2Q37331331-486327C7-355C-4F68-B6E4-011A3BEC58CCQ37366826-0434BADE-45B5-4E3B-9F6C-1E25FAD27B0CQ37629367-AF932C1C-A625-41E4-B642-AD40660A58A0Q37694578-252F0098-AEBF-4992-ADA7-7FD8742C8C4DQ37885717-1343B5C6-BD9A-44BC-9042-28D74ACEEF66Q37911549-6783D85F-AC26-4FE7-BC64-F29488CC81E3Q38072203-E9CB307E-4CA4-47D4-89B5-04F1ACBE6B47Q38122004-3DBC8F71-0E7C-4118-AC64-9A55849AB394Q38254745-0ABBF0F3-3BD7-42D0-AA19-DFD8AB034BACQ38575560-C51483AE-3461-41CF-B62D-759BE2845546Q38597984-05C2EF07-A834-4818-8C03-84B8260ACFBEQ38833040-E3E58381-AADE-4178-AA5C-985EEC2520A6Q39047697-1D158CDB-ED6C-44F9-A5C2-8D7860CD3CBBQ41094907-8F75D128-0BB6-4EF1-BD9A-13FA80D7F7B9Q41153628-F97A47B1-F676-4376-ACEB-5613771FCA77Q41646131-7F91A079-6FCC-4D41-850D-4FFE4B97DB80Q48208276-776EFEC9-6442-4E0B-8C54-B0A127E145E7Q48268281-3EF69143-BEAA-4CD4-8171-EC3ACCBF034CQ49179704-01B0DA11-4C49-4689-AC3B-8DAEF153159EQ50937164-11EE4BD3-474D-4C09-91FC-0B22528F9D4DQ51373270-1E5BEC28-FA64-4C7C-B021-775FE8058B5BQ53553149-418540AF-4408-4710-BBE6-3BCA637C5A48Q58447986-7E6B55CE-2C22-4D9B-AC0D-61FA078DF3A9
P2860
Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@ast
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@en
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@nl
type
label
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@ast
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@en
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@nl
prefLabel
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@ast
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@en
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@nl
P2093
P50
P356
P1476
Secretion and dipeptidyl pepti ...... ared to lean, nondiabetic men.
@en
P2093
Jenny Vikman
Katarina Jelic
Marianne O Larsen
Ola Lindgren
Richard D Carr
P304
P356
10.1210/JC.2009-2054
P407
P577
2009-12-11T00:00:00Z